Pathway enrichment analysis results showed that RRP treatment of osteoporosis was most closely related to the estrogen signaling pathway, and it is also associated with HIF-1, MAPK, and PI3K-Akt signaling pathways. This evidence concerns the gene HIF1A and osteoporosis.